A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...

The once- and twice-daily GLP-1 RAs are now ... weekly injection is linked to an Fc fragment of human IgG4. It has similar efficacy to other GLP1 agonists, with seemingly lower incidence of ...

GLP-1 agonists for weight loss are now commonly used for adults ... In a 56 week study of liraglutide, a daily 3.0 mg subcutaneous injection resulted in 51 of 113 (43.3%) adolescent participants ...

and Wegovy injections for weight management. NVO’s arch-rival, Lilly, markets tirzepatide, a dual GIP and GLP-1 receptor agonist, as Mounjaro for T2D and Zepbound for obesity. In the past three ...

ASC30 oral tablet demonstrated superior PK properties (including a longer t1/2 and higher AUC) to other small molecule oral GLP-1 ... agonist and has unique and differentiated properties that enable ...

NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand ... The medications are known as glucagon-like peptide-1 receptor agonists (GLP-1RA) and include Mounjaro and ...

The pens make the injections much easier, and more painless ... but they do have a good sketch of what they do. These drugs are known as GLP-1 agonists. GLP-1 is a naturally occurring hormone that ...